Few studies have reported the clinical utility of LIA in detecting anti-SAE1 autoantibody and its impact on different clinical subsets, including patients with IIM or other CTDs without myositis in Asian cohorts, considering the low prevalence of anti-SAE1 autoantibody among Asians. The gene discussed is SAE1; the disease is acquired idiopathic inflammatory myopathy.